Opposite to common assumption of incurability of such patients, in a recent much debated study the actuarial ten-year prostate cancer-specific survival was as high as 88% in cohort of patients who had PSA between 0.1 and 2.0 ng/mL two months post prostatectomy [10]. The gene discussed is KLK3; the disease is prostate carcinoma.